TrialBritish journal of clinical pharmacology2026

Efficacy and safety of a selective partial agonist for nociception/orphanin-FQ peptide (NOP) receptors in patients with insomnia disorder.

Garth T Whiteside et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.